STAT3 and STAT5 phosphorylation clearly plays a pivotal role in the proliferation and survival of a wide variety of tumor cells and that blockade of JAK/STATs signals can provide a potent therapeutic strategy for RCC [13, 34, 35, 53]. This evidence concerns the gene STAT5B and renal cell carcinoma.